Class IIOngoing

fentaNYL Citrate recall

FDA recall D-0548-2026 · initiated May 12, 2026

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Subpotent Drug

Details

Product: fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water, IntegraDose Compounding Services LLC, 3650 Victorie St N, Suite 900, Shoreview, MN, NDC 71139-6030-1.
Recalling company: IntegraDose Compounding Services LLC
Classification: Class II
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: Nationwide.
Initiated: May 12, 2026
FDA report date: May 27, 2026

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0548-2026 ↗

← All drug recalls